UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 22, 2015 (June 19, 2015)


 

Neuralstem, Inc.

(Exact name of registrant as specified in Charter)

 

 

Delaware   000-1357459  

52-2007292

(State or other jurisdiction of

incorporation or organization)

  (Commission File No.)   (IRS Employee Identification No.)

 

20271 Goldenrod Lane, 2nd Floor, Germantown, Maryland 20876

(Address of Principal Executive Offices)

 

(301) 366-4960

(Issuer Telephone number)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On June 19, 2015, Neuralstem, Inc. (“Company”) held its 2015 annual meeting at which all proposals brought before the meeting and requiring approval were approved by the requisite vote. The final results of the stockholder vote on each proposal brought before the meeting were as follows:

 

(a) Proposal 1. Each of the three (3) Class I Director nominees to serve for a three-year term expiring at the 2018 Annual Meeting was elected based upon the following votes:

 

      Broker
Nominee Votes For Votes Withheld Non-Votes
Scott Ogilvie 18,135,774 1,938,047 55,101,728
Sandford Smith 19,701,808 372,013 55,101,728
Dr. Catherine Sohn 19,717,776 356,045 55,101,728

 

 

(b) Proposal 2. The ratification of Stegman & Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015 was ratified based upon the following votes:

 

      Broker
Votes For Votes Against Abstentions Non-Votes
74,221,882 494,701 458,966 --

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEURALSTEM, INC  
         
  By:  

/s/ I. Richard Garr

 
     

I. Richard Garr

Chief Executive Officer

 

 

Dated: June 22, 2015